patents
Denmark champions patents as fundamental to preventing climate change
By AWA | Posted on September 26, 2019
Danish Minister for Industry, Business and Financial Affairs Simon Kollerup stated that protecting the intellectual property rights of innovative green companies is essential. Kollerup’s comments come as a Joint Report from the European Patent Office (EPO) and European Union Intellectual Property Office (EUIPO) published on IPR-intensive industries and economic performance in the European Union. The...
Tags: CCMT, climate-change, Denmark, EPO, EUIPO, green innovations, green transition, patents
Brexit may stall Germany’s ratification of the UPCA
By AWA | Posted on August 26, 2019
The German Justice Ministry expressed earlier this month that the government will not ratify the Unified Patent Court Agreement (UPCA) until the implications of Brexit are clear. A letter from the Ministry in answer to questions of parliament stated: “The issue of the withdrawal of the United Kingdom from the European Union (so-called Brexit) and...
Tags: Brexit, EU, Germany, patents, unitary patent, UPC, UPCA
EPO and EUIPO study finds link between IPR and SME growth
By AWA | Posted on July 9, 2019
A recent study by EPO and EUIPO explores the relationship between prior IPR activities of SMEs and the likelihood of experiencing a high-growth period. The purpose of the research was to investigate the following questions: Can the filing of IP rights be used as a reliable predictor of the likelihood that an SME will experience...
Tags: designs, EPO, EUIPO, high-growth, IPR, patents, SMEs, trademarks
What export waivers mean for European Supplementary Protection Certificates
By Louise Jonshammar | Posted on February 12, 2019
Louise Jonshammar takes a closer look at the final mandate surrounding export waivers for European Supplementary Protection Certificates, what it means for applicants and holders and the importance of monitoring once the Regulation comes into effect Supplementary Protection Certificates (SPC) offer patent owners an extension of up to five years of the basic patent’s...
Tags: Brexit, EU, export waiver, generics, Infringement, patents, SPC
ExThera Medical: Drug resistance
By AWA | Posted on November 19, 2018
Based in Martinez, California (US), ExThera Medical (ExThera) has developed a state-of-the-art device that filters harmful bacteria and viruses from patients’ blood in a dialysis-like circuit. This device, named Seraph, is proving to be a promising alternative for treating drug-resistant bloodstream diseases, which remain a significant health concern worldwide A serious blood problem Bacterial bloodstream...
Filed under: Interviews
Tags: blood, bloodstream, exthera medical, Intellectual Property, patents, San Francisco, seraph, USA
Client-attorney privilege for non-US attorneys: Can clients trust that privileged communications with their patent attorneys will not be disclosed in US courts?
By Mikkel Roed Trier | Posted on November 9, 2018
The legal situation in the US concerning client-attorney privilege for patent attorneys has seen some development in recent years. But, especially for non-US patent attorneys, the situation is still uncertain. A recent order of the US International Trade Commission (ITC), 3Shape, confirms the uncertainty concerning foreign patent attorneys. Federal Circuit decision Queen’s of 2016 introduced for...
Tags: 3Shape, client-attorney privilege, ITC, non-US patent attorneys, patent attorneys, patents, PTAB, Queen's, US
Co-inventorship to a patent had not been proved
By Mette Parlev | Posted on November 7, 2018
On 10 October 2018 the Eastern High Court in Denmark gave judgement in a case between Coloplast and Hollister, regarding claimed co-inventor ship in a patent application. In the case Coloplast claimed to be mentioned as co-inventor on and co-owner of a patent application filed by Hollister. The reason Coloplast claimed to be co-inventor was that...
Tags: Coloplast, Denmark, Hollister, patents
Affibody molecule: A molecule that can detect breast cancer
By AWA | Posted on October 31, 2018
Every month is breast cancer awareness month for Swedish Biopharmaceutical R&D company Affibody, which has developed unique molecular technologies to localise cancerous tumours and individualise drug treatment for patients Director of Alliance and IP Management at Affibody Caroline Ekblad has been with the Solna based company since 2007. She started out working with research, but...
Filed under: Interviews
Tags: Affibody, Albumod, biopharmaceuticals, breast cancer, cancer, diagnostics, Intellectual Property, molecules, patents
Bracing ourselves for a “no Brexit deal”?
By AWA | Posted on October 19, 2018
The point of no return, the date of jumping off the cliff, the end of the conveyor belt, or as we say in Swedish “a dear child has many names” – 29 March 2019 is now very quickly approaching. On 17 October, the EU27 leaders met at the European Council to discuss Brexit, and even...
Tags: 29 March 2019, Brexit, Britain, EU27, Europe, European Union, Intellectual Property, patents, RCD
China’s innovation rise – patent landscape review and outlook
By Ai-Leen Lim | Posted on October 18, 2018
For the first time in 11 years China broke into the world’s top 20 most innovative economies in the Global Innovation Index for 2018. The report – which was jointly published by Cornell University, INSEAD and the World Intellectual Property Organisation – annually ranks 126 economies based on 80 indicators. China’s number 17 ranking is...
Recent contributors
Senior Associate, Attorney at Law
Partner, Attorney at Law, Group Vice President
Partner, Attorney at Law, Business Area Manager
Senior Counsel, European Patent Attorney
Partner, European Patent Attorney, UPC Representative, Business Area Manager